Anti-NKG2A Monoclonal Antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-NKG2A Monoclonal Antibody, covering 2025-03-24 to 2025-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation [Phase 2]